Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06773845 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

NCT06773845 · ClinicalTrials.gov record · last posted 2026-08-20

Building Evidence for Ablative Internal Radiation Therapy in Localized HCC Beyond the Up-To-7 Criteria

Name: Building Evidence for Ablative Internal Radiation Therapy in Localized HCC Beyond the Up-To-7 Criteria — clinical trial record (NCT06773845)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: BEAT-UT7

StatusRecruiting

PhasePhase 2

SponsorSeoul National University Hospital

Started2025-03-11

View on ClinicalTrials.gov ↗

from the ClinicalTrials.gov record

At four major centers in Korea, patients with hepatocellular carcinoma (HCC) that exceed the up-to-7 criteria yet remain locally confined will undergo ablative radioembolization using Yttrium-90 glass microspheres, guided by a standardized dosimetry method. Their treatment response, survival outcomes, and adverse events will be monitored for two years following the procedure.

Protocol amendment history 3 changes detected by DataLookout

2026-08-21

Trial sites expanded: 4 → 8 locations

2026-08-21

Primary completion pushed: 2027-12-31 → 2028-12-31

2026-08-21

Completion pushed: 2029-12-31 → 2030-12-31

Trial Details

NCT Number	NCT06773845
Lead Sponsor	Seoul National University Hospital Collaborators: Boston Scientific Corporation
Conditions	Hepatocellular Carcinoma (HCC), Radioembolization
Enrollment	100 participants
Start Date	2025-03-11
Primary Completion	2028-12-31 (estimated)
Study Completion	2030-12-31 (estimated)
Updated on ClinicalTrials.gov	2026-08-20